|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 18, 2024 |
Title |
Control_2 |
Sample type |
SRA |
|
|
Source name |
Bacterial cells
|
Organism |
Pseudomonas aeruginosa |
Characteristics |
cell type: Bacterial cells strain: PAO1 treatment: Control (Without treatment)
|
Growth protocol |
The overnight culture of P. aeruginosa PAO1 propagated in LB was diluted 1:1000 in fresh media and incubated in the presence of Ar5 (16 µg/mL) and PAβN (16 µg/mL) for 17 h at 37 ºC.
|
Extracted molecule |
total RNA |
Extraction protocol |
After incubation, the 5 mL culture was centrifuged, and the pellet was stored overnight at -80 ºC. The pellet was removed from the freezer, mixed with 1 mL TRIzolTM reagent (Invitrogen), and immediately placed on ice. The solution was subject to bead beating for 45 sec, immediately placed on ice, and centrifuged at 13,000 ×g for 10 min at 4 ºC. The supernatant was transferred to another tube and gently mixed with an equal volume of absolute ethanol (molecular biology grade). Further, the total RNA was extracted using the RNeasy Mini Kit (QIAGEN). NEB Ultra II directional RNA-Seq Library Prep kit (NEB, Cat# E7760L) protocol was used to prepare libraries for total RNA sequencing. An initial Concentration of 100 ng of total RNA was taken for the assay. First, the total RNA was hybridized with QIAseq® FastSelect™ –5S/16S/23S reagent mixture (Qiagen, Cat# 335927) by heat-fragmenting and cooling the reaction from 75°C to 25°C, followed by Bead clean-up. The cleaned-up ribo-depleted RNA fragments were copied into first-strand cDNA using reverse transcriptase. Second strand cDNA synthesis was performed using DNA Polymerase I and RNase H enzyme. The cDNA fragments were then subjected to a series of enzymatic steps that repair the ends, tails the 3' end with a single 'A' base, followed by ligation of the adapters. The adapter-ligated products were then purified and enriched using the following thermal conditions: initial denaturation of 98°C for 30sec; 13 cycles of - 98°C for 10sec, 65°C for 75sec; final extension of 65°C for 5 mins. The amplified libraries were purified and checked for fragment size distribution on Fragment Analyzer using HS NGS Fragment Kit (1-6000bp) (Agilent, Cat# DNF-474-1000).
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NovaSeq 6000 |
|
|
Data processing |
Read alignment: The paired-end reads are aligned to the reference Pseudomonas aeruginosa genome (https://ftp.ncbi.nlm.nih.gov/genomes/all/GCF/000/006/765/GCF_000006765.1_A M676v1/). Alignment was performed using HISAT2 (2.1.0). Expression estimation: The aligned reads are used to estimate the gene expression. The raw read counts were estimated using FeatureCount (1.5.2). Read count data were normalized using DESeq2. Differential expression analysis: The raw read counts were normalized using DESeq2.The ratio of normalized read counts for treated over control was taken as the fold change. Genes were first filtered based on the p-value (<= 0.05). The distribution of these log2 (foldchange) values was found to be normally distributed. Those genes which were found to have -1 <= log2(foldchange) >= 1 were considered as statistically significant. Assembly: https://ftp.ncbi.nlm.nih.gov/genomes/all/GCF/000/006/765/GCF_000006765.1_A M676v1/ Supplementary files format and content: Microsoft excel files containing normalised read counts, Log2 fold change, Log2 scale values
|
|
|
Submission date |
Aug 02, 2022 |
Last update date |
Mar 18, 2024 |
Contact name |
Nisha Mahey |
E-mail(s) |
nishamahey95@gmail.com
|
Phone |
08427496212
|
Organization name |
CSIR-Institute of Microbial Technology
|
Department |
BERPDC
|
Lab |
Clinical Microbiology and Antimicrobial Research Laboratory
|
Street address |
Sector 39A
|
City |
Chandigarh |
State/province |
Chandigarh |
ZIP/Postal code |
160036 |
Country |
India |
|
|
Platform ID |
GPL26913 |
Series (1) |
GSE210309 |
Pyrrole-based inhibitors of RND-type efflux pumps reverse antibiotic resistance and display antivirulence potential |
|
Relations |
BioSample |
SAMN30101341 |
SRA |
SRX16769667 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|